The weekly litigation news digest is live. Subscribe now

IP Verse

Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses Thereof - EP3293202

The patent EP3293202 was granted to Cantargia on Feb 7, 2024. The application was originally filed on Mar 5, 2015 under application number EP17185792A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3293202

CANTARGIA
Application Number
EP17185792A
Filing Date
Mar 5, 2015
Status
Patent Maintained As Amended
Jan 5, 2024
Publication Date
Feb 7, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BLUEFIN BIOMEDICINENov 24, 2021DEHNSADMISSIBLE
ICHNOS SCIENCESNov 24, 2021-ADMISSIBLE
ZWICKER SCHNAPPAUF & PARTNERNov 24, 2021ZWICKERADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0213303
DESCRIPTIONEP2213683
DESCRIPTIONUS4235871
DESCRIPTIONUS4816567
DESCRIPTIONUS5851451
DESCRIPTIONUS7960512
DESCRIPTIONWO03059973
DESCRIPTIONWO2005007197
DESCRIPTIONWO2011021014
DESCRIPTIONWO2012098407
OPPOSITIONEP3020730
OPPOSITIONWO2012098407
OPPOSITIONWO2014113433
OPPOSITIONWO9623067
SEARCHWO2012098407

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents